APA (7th ed.) Citation

A, M., L, T., S, A., AO, Z., M, J., MS, C., . . . A, H. (2024). Retraction Note: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem cell research & therapy, 15(1), 110. https://doi.org/10.1186/s13287-024-03733-0

Chicago Style (17th ed.) Citation

A, Markov, et al. "Retraction Note: Mesenchymal Stem/stromal Cells as a Valuable Source for the Treatment of Immune-mediated Disorders." Stem Cell Research & Therapy 15, no. 1 (2024): 110. https://doi.org/10.1186/s13287-024-03733-0.

MLA (9th ed.) Citation

A, Markov, et al. "Retraction Note: Mesenchymal Stem/stromal Cells as a Valuable Source for the Treatment of Immune-mediated Disorders." Stem Cell Research & Therapy, vol. 15, no. 1, 2024, p. 110, https://doi.org/10.1186/s13287-024-03733-0.